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Background and PurposeaaThe most important treatment for subcortical vascular dementia 
(SVaD) is controlling the blood pressure (BP). However, the few studies that have investigated the 
relationships between diurnal BP rhythm and subcortical ischemic vascular cognitive impairment 
have produced inconclusive results. In the study presented here, the 24-hour BP values of three 
groups of subjects-patients with subcortical vascular mild cognitive impairment (SvMCI), pa-
tients with SVaD, and normal controls-were compared using working criteria and 24-hour am-
bulatory BP (ABP) monitoring. 
MethodsaaThe subjects (42 patients with SVaD, 37 patients with SvMCI, and 30 controls) were 
selected according to the study’s inclusion/exclusion criteria. All subjects underwent brain 
magnetic resonance (MR) imaging and MR angiography, detailed neuropsychological testing, 
and 24-hour ABP monitoring.   
ResultsaaThe prevalence of nondippers differed markedly between the control group and both 
the SVaD and SvMCI groups. Loss of nocturnal dipping was significantly associated with SVaD 
[odds ratio (OR), 4.827; 95% confidence interval (CI), 1.07-12.05]. 
ConclusionsaaIt was found that SVaD is associated with loss of nocturnal BP dipping com-
bined with increased pulse pressure and systolic BP (SBP) variability. Correction of these factors 
could therefore be important in the prevention of SVaD, independent of measures used to 
reduce BP.    J Clin Neurol  2009;5:139-145
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Introduction 
 
Small-vessel disease in the brain accounts for one quarter 
of ischemic strokes and is probably the main cause of vas-
cular cognitive impairment.
1,2 Small-vessel disease manifests 
as abnormalities on magnetic resonance (MR) imaging (MRI), 
mainly in subcortical areas such as the basal ganglia, fron-
tal white matter, periventricular white matter, and the bilat-
eral thalamic areas. Although there are no consensus criteria 
for it, subcortical vascular dementia (SVaD) is thought to be 
the natural successor to subcortical vascular mild cognitive 
impairment (SvMCI), in the same way that vascular demen-
tia is the successor to vascular mild cognitive impairment 
(MCI).
2 
After age, hypertension is the most important risk factor 
for small-vessel disease, and it is becoming increasingly clear 
that there is a complex and dynamic relationship between 
blood pressure (BP) and subcortical white-matter ischemic 
injury. It has been found that an elevated BP in midlife is as-
sociated with a higher prevalence of white-matter injury in 
the brain and cognitive decline in subsequent years, and that 
a lower BP in old age is associated with worse intellectual 
function.
3-7 However, no clear relationship has been demons-
trated between diurnal BP rhythm and subcortical ischemic 
vascular cognitive impairment (VCI). 
Noninvasive ambulatory BP (ABP) monitoring is used 
to study BP under normal living conditions as it provides a 
reliable estimate of the habitual diurnal BP rhythm, which  
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may be used to independently predict hypertension-related 
complications.
8 In normal subjects, the mean nocturnal sys-
tolic BP (SBP) is 10-20% lower than the mean daytime SBP, 
a phenomenon known as dipping.
9 Alteration of this noctur-
nal dip in BP, either nondipping (where the nocturnal SBP 
decrease is less than 10% of the daytime SBP) or hyperdip-
ping (where the nocturnal SBP decrease is more than 20% 
of the daytime SBP), is associated with an elevated risk of 
end-organ injury, particularly to the heart, brain, and kid-
neys.
8,10-12 Many studies have shown that the degree of noc-
turnal BP dipping determines the consequent type of cerebro-
vascular injury. O’Brien et al.
10 reported that strokes are sig-
nificantly more likely to occur in nondipping hypertensive 
persons than in dipping hypertensive ones. More recently, 
Staessen et al.
11 found that the incidences of stroke and myo-
cardial infarction were higher in nondippers than in those 
with a normal dipping pattern.
 However, the few studies 
that have been published on the relationship between the 
ABP profile and the progression of small-vessel disease in 
the brain have produced conflicting results. Some studies 
suggest that the severities of small-vessel disease and cogni-
tive dysfunction are affected by the loss of nocturnal BP 
dipping or SBP variability, whereas others have produced 
opposing results. This apparent disparity may be due to dif-
ferences in the number of study subjects and the method-
ologies and assessment techniques applied in the different 
studies.
13,14 
SvMCI, which is the preclinical stage of SVaD, has be-
come far more important than SVaD itself due to the pro-
gression of small-vessel disease, although no definite cri-
teria have been established. This recent recognition and the 
lack of criteria are due to there being few published data 
related to SvMCI. However, much of the established knowl-
edge on SvMCI, which has been accrued using modified 
MCI criteria, indicates that white-matter lesions (WMLs) 
revealed by MRI and the clinical vascular symptoms or 
signs facilitate the diagnosis of SvMCI. 
The study presented here analyzed and compared 24-
hour BP values of control subjects and SvMCI and SVaD 
patients, with the aim of determining whether 24-hour BP 
patterns differ between SvMCI and SVaD patients. 
 
Methods 
 
Subject selection 
SvMCI and SVaD patients were selected consecutively from 
the memory disorder clinics at Ewha Womans University 
Hospital, Seoul National University Bundang Hospital, and 
Konyang University Hospital, South Korea, and normal con-
trols were recruited at the Department of Cardiology, be-
tween March 2006 and April 2008. All of the subjects gave 
their informed consent to participate in the study and under-
went brain MRI and MR angiography. The impairments in 
each of the cognitive domains were evaluated with the aid 
of a detailed neuropsychological test, the Instrumental Ac-
tivities of Daily Living (I-ADL) scale, and the overall severity 
was assessed using the Clinical Dementia Rating (CDR) scale. 
The subjects were assigned to one of the three groups ac-
cording to the following inclusion criteria: 
1) Control group: Subjects in this group exhibited cogni-
tivefunction performances in the neuropsychological tests 
that were within the normal range, and had no lobar or cor-
tical lesions on MRI. 
2) SVaD/SvMCI groups: The etiology underlying the cog-
nitive impairment of the SVaD and SvMCI patients was 
most probably the WMLs on MRI with no evidence of any 
other etiology, such as prominent hippocampal atrophy, cor-
tical or large territorial infarction, or severe amnesia of the 
encoding deficit type. 
3) SVaD group: These patients met the criteria for vas-
cular dementia described by the Diagnostic and Statistical 
Manual of Mental Disorders-Fourth Edition, the objective 
cognitive decline below the 16th percentile of norms on st-
andardized neuropsychological tests, and they had CDR, I-
ADL, and Hachinski ischemic (HI) scores of ≥1, ≥8, ≥5, 
respectively. We excluded those SVaD patients with a CDR 
score of 0.5 and an I-ADL score of 8 (i.e., very mild stage 
of the disease). 
4) SvMCI group: The objective cognitive decline of these 
patients was below the 16th percentile of norms on standar-
dized neuropsychological testing, and they exhibited CDR, 
I-ADL, and HI scores of 0.5, <8, and ≥5, respectively.
15,16 
 
Conventional risk factors 
Hypertension was diagnosed if the patient had either pre-
viously used or was currently using antihypertensive agents 
at the time of the hospital visit, and if the patient had a mean 
SBP of ≥140 mmHg or a mean diastolic BP (DBP) of ≥90 
mmHg, as measured on at least two separate occasions with 
the patient in a sitting position. Diabetes mellitus was defined 
as either a fasting glucose level of >126 mg/dL (as measured 
on more than two occasions) or if the patient was currently 
using antidiabetic medication at the time of their hospital 
visit. The presence of dyslipidemia was indicated by a fast-
ing total cholesterol level of >220 mg/dL, a fasting trigly-
ceride level of >200 mg/dL, or the use of a lipidlowering 
agent at the time of the patient’s hospital visit. Cigarette smok-
ing was defined as being a current smoker at the time of the 
patient’s hospital visit. None of the patients had a history of 
cardiovascular or cerebrovascular disease.  
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Blood pressure measurement 
Noninvasive ABP monitoring was performed on weekdays, 
starting early in the morning. Measurements were taken 
from the nondominant arm every hour during the day and 
night. The subjects were instructed to perform their normal 
daily activities and to adhere to their normal sleep patterns. 
For analysis, the daytime and nighttime episodes were de-
fined as those occurring between 07 : 00 and 21 : 00 hours and 
between 22 : 00 and 06 : 00 hours, respectively. The subjects’ 
mean BP, mean heart rate, and diurnal BP rhythm were de-
termined for these episodes. The mean SBP, DBP, mean ar-
terial pressure, pulse pressure (PP), and heart rate values were 
computed for the daytime, nighttime, and 24-hour episodes 
using a custom-made computer program running on a porta-
ble autonomic function recorder. 
According to recently issued guidelines,
1,16,17 our partici-
pants could be classified according to their BP character-
istics and dipper status. The ABP values were dichotomized 
into low and high groups as follows: daytime SBP (≤135 
and >135 mmHg, respectively), daytime DBP (≤80 and >80 
mmHg, respectively), nighttime SBP (≤120 and >120 mmHg, 
respectively), and nighttime DBP (≤70 and >70 mmHg, res-
pectively). The patients were also divided into three dipper-
status categories for nocturnal BP: dippers, non-dippers, and 
reverse dippers, defined as a difference in the mean BP be-
tween the daytime and nighttime hours of >10%, 0-10%, and 
<0, respectively. SBP variability and PP could be divided into 
two categories: low (≤15 mmHg) and high (>15 mmHg) SBP 
variability, and low (≤50 mmHg) and high (>50 mmHg) PP. 
 
MRI investigation and white-matter lesions scoring 
MRI scans were obtained using a 3.0-T device (Intera NT, 
Philips, Eindhoven, the Netherlands) and a 1.5-T device 
(Avanto Syngo, Siemens, Erlargen, Germany). The scan pro-
tocol included determining the axial proton density, T2-
weighted axial imaging, fluid-attenuated inversion recovery 
(FLAIR) sequences, T1-weighted axial imaging, and MR 
angiography at a slice thickness of 5 mm. Lacunes were de-
fined as lesions that were 3-15 mm in diameter and that ex-
hibited a low-intensity signal on the T1-weighted images, but 
a high-intensity signal on the T2-weighted and FLAIR im-
ages. WMLs were defined as diffuse hyperintensities located 
in the subcortical and periventricular white matter on T2-
weighted images. For MRI, the number of lacunes was grad-
ed as follows: absent, 0; one or two lacunes, 1; three to five 
lacunes, 2; and more than five lacunes, 3. A WML was re-
garded as a periventricular hyperintensity (PVH) when it 
was adjacent to a ventricle; otherwise, the lesion was deemed 
to be a deep white-matter hyperintensity (DWH). The PVHs 
and DWHs were scored semiquantitatively according to the 
classification of Fazekas.
17 The PVHs were classified as fol-
lows: absent, 0; cap or pencil-thin lining, 1; smooth halo, 2; 
and irregular PVH extending into the deep white matter, 3. 
The DWHs were classified as follows: absent, 0; punctuated, 
1; becoming confluent, 2; and confluent, 3. The MRI data 
were evaluated by two neurologists who were blinded to 
both the BP data and the clinical findings. 
 
Cognitive assessment 
Cognitive function was tested by applying the Seoul Neu-
ropsychological Screening Battery, which is a standardized 
neuropsychological battery that comprises tests for attention, 
visuospatial function, verbal and visual memory functions, 
language-related function, and frontal executive functions.
18 
These tests include the digit span test (forward and back-
ward) for attention, the Korean version of the Boston Nam-
ing Test, written calculations for testing language and re-
lated functions, Rey-Osterrieth Complex Figure Test (RCFT) 
copying, time and place orientation, free recall, delayed re-
call trials and recognition scores of the Seoul Verbal Learn-
ing Test and RCFT immediate, 20-min-delayed recall trials, 
and recognition scores for memory. The following tests were 
also applied to assess frontal executive function: impersis-
tence, contrasting program, go/no-go test, fist-edge-palm 
test, Luria loop, phonemic and semantic Controlled Oral 
Word Association Test, and Stroop Test. 
 
Statistical analysis 
The demographics, risk factors, and BP data of the study 
groups were compared first. The continuous variables are ex-
pressed as mean±SD values, and the categorical variables 
are expressed as the percentage of patients affected. The cli-
nical variables in the three study groups were compared, 
with the BP data analyzed using one-way ANOVA and 
through multiple comparisons of the three groups employing 
Tukey testing. The associations were evaluated by estimat-
ing the odds ratios (ORs) for SVaD and its risk factors, as 
well as for each type of subcortical ischemic lesion and risk 
factor. The grade of subcortical ischemic lesion was dicho-
tomized as follows: grades 0 and 1 were assigned to those 
considered as early findings, while grades 2 and 3 were as-
signed to those considered as advanced findings. The ORs 
and 95% confidence intervals (CIs) were calculated using a 
logistic regression model. The contributing factors that were 
included in the logistic regression model were the conven-
tional risk factors, the MRI findings for each subcortical is-
chemic lesion, and the 24-hour BP values. Correlations be-
tween the 24-hour BP values and the neuropsychological 
findings were analyzed using Pearson’s correlation test ad-
justed for age and education level. Statistical analyses were  
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performed with SPSS (Windows version 13, SPSS, Chicago, 
IL, USA), using an alpha level of 0.05. 
 
Results 
 
General data 
The initial sample comprised 123 patients: normal controls 
(n=34) and patients with SvMCI or SVaD (n=89). Some of 
the subjects were excluded due to 1) strategic infarction de-
mentia (n=2), 2) psychiatric disorder (n=2), 3) a medical dis-
ease affecting their cognition (n=1), 4) severe hippocampal 
atrophy (n=2), 5) a heart disease such as myocardial infarc-
tion or atrial fibrillation (n=2), 6) midlife-onset hyperten-
sion (n=2), 7) a modified Rankin Scale score of ≥5 (n=1), 
or 8) MR-angiogram-proven severe large-vessel stenosis (n= 
2). This led to the final experimental cohort comprising 79 
patients with SvMCI or SVaD, plus 30 normal controls. Of 
those with a subcortical vascular event, 37 were diagnosed 
as having SvMCI and 42 were diagnosed as having SVaD. 
The entire cohort of 109 subjects comprised 63 men and 46 
women aged 69.9±4.12 years (range, 64-76 years). Table 1 
lists the demographic data, conventional risk factors, and 
MRI findings for each subcortical-ischemic-lesion type, and 
the 24-hour BPs in the three study groups. None of the subject 
demographics differed significantly between the three groups. 
 
Comparison of 24-hour blood pressure values 
in the subcortical vascular mild cognitive impair-
ment, subcortical vascular dementia, and control 
groups 
All BP values except for daytime DBP differed significantly 
between the three study groups. Multiple comparisons reveal-
ed that the daytime and nighttime SBPs were significantly 
higher in the SvMCI group than in the control group, and 
that the SBP variability and PP were significantly higher in 
the SVaD group than in the control group. The prevalence of 
the dipper type also differed markedly between the SVaD 
and control groups and between the SVaD and SvMCI groups 
(Table 2). Six patients (30%) in the control group exhibited a 
nondipper status, while 17 (45%) and 27 (65%) patients in the 
SvMCI and SVaD groups, respectively, exhibited a nondip-
per status; there were no hyperdippers. 
 
Associations between subcortical vascular mild 
cognitive impairment and subcortical vascular 
dementia, and the conventional risk factors and 
24-hour blood pressure values 
The ORs for the risk factors of SVaD are presented in Table 
3. They were greatest for PVH (OR, 1.95; 95% CI, 1.137-
3.343) and DWH (OR, 1.80; 95% CI, 1.042-3.109). More-
over, there was a significant association between the nondip-
per type and presence of SVaD (OR, 4.827; 95% CI, 1.07-
12.05). 
 
Association between 24-hour blood pressure values 
and subcortical ischemic lesions 
Table 4 lists the OR and 95% CI for each advanced sub-
cortical ischemic lesion type, relative to the early-findings 
groups, for 24-hour BP values. High daytime SBP (OR, 
3.032; 95% CI, 1.086-8.465), high nighttime SBP (OR, 
3.538; 95% CI, 1.212-10.328), and absence of dipping (OR, 
4.178; 95% CI, 1.830-8.826) were associated with PVH; 
Table 1. Demographic and clinical characteristics of the subjects
Study group 
 
SvMCI (n=37)  SVaD (n=42)  Control (n=30) 
p† 
Age (years) 71.59±5.59 69.98±5.83 68.77±3.90 0.095 
Education level (years)  05.41±3.18  06.35±4.47  06.24±3.14 0.495 
Sex (M/F) 22/15  23/19  18/12  0.860 
Hypertension 26  (70%) 34  (80%) 24 (80%) 0.802 
Diabetes 13  (35%) 19  (45%)  09 (30%) 0.974 
Hypercholesterolemia 11  (30%) 15  (35%)  06 (20%) 0.669 
SM  07 (20%)  06 (15%)  09 (30%) 0.545 
LVH  09 (25%) 15  (35%)  06 (20%) 0.692 
Anti-HTN medication  22 (60%) 34  (80%) 21  (70%) 0.602 
K-MMSE 22.06±5.04 19.19±4.14 28.27±1.04 0.000* 
Grade of PVH  01.73±0.77  02.19±0.67  00.57±0.48 0.000* 
Grade of DWH  01.62±0.64  02.29±0.60  00.20±0.76 0.000* 
Grade of LI  01.00±0.71  00.96±0.70  00.16±0.79 0.000* 
The data are mean±SD values or n (%). *p<0.05, †Calculated using ANOVA.   
SvMCI: subcortical vascular mild cognitive impairment, SVaD: subcortical vascular dementia, HTN: hypertension, SM: smoking, LVH: left 
ventricular hypertrophy, LI: lacunar infarcts, PVH: periventricular hyperintensities, DWH: deep white-matter hyperintensity, K-MMSE: Korean 
adaptation of the Mini-Mental State Examination.  
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SBP variability was associated with DWH (OR, 3.375; 95% 
CI, 1.007-11.312). 
 
Correlation between 24-hour blood pressure values 
and the results of neuropsychological testing 
The age- and education-adjusted partial correlation analysis 
revealed that loss of dipping was significantly associated with 
reduced attention (r=0.267, p=0.019) and frontal executive 
dysfunction (r=0.348, p=0.002), and that SBP variability 
was significantly associated with reduced attention (r=-0.258, 
p=0.024), frontal executive dysfunction (r=-0.243, p=0.033), 
and visuospatial dysfunction (r=-0.305, p=0.007). PP was as-
sociated with reduced attention (r=-0.258, p=0.024)(Table 4). 
 
Discussion 
 
The main findings of this study are twofold: 1) the preva-
lence of disruption of the diurnal BP rhythm was higher in 
the patients with SvMCI or SVaD than in the controls, and 
was associated with cognitive dysfunction; and 2) the preva-
lence rates of high-grade SBP variability and increased PP 
were higher in patients with SVaD than in patients with 
SvMCI and in the controls. 
Most previous studies found that hypertension was close-
ly related to WML and cognition, and it is certain that the 
size of an ischemic WML is correlated with the SBP and 
cognitive impairment.
4,19-24 However, there is considerable 
controversy regarding the relationships between BP variabil-
ity, ischemic WMLs, and cognition. It is noteworthy that van 
Boxtel et al.
14 systematically examined the relationships be-
tween BP, WMLs, and cognitive performance in the same 
cohort of hypertensive subjects with asymptomatic cerebro-
vascular damage, and found no conclusive evidence of a 
connection between diurnal BP variation and early target-
organ damage in the brain, although the ABP profile may 
Table 2. Comparison of 24-hour blood pressure (BP) between the SvMCI, SVaD, and control groups
Variable  SvMCI (n=37)  SVaD (n=42)  Control (n=30)  p  Post hoc† (Tukey) 
Daytime SBP  141.96±10.72 130.92±10.89 131.05±9.520 0.002*  SvMCI>control 
Nighttime SBP 
 
136.58±13.85 
 
129.66±11.92 
 
123.33±10.48 
 
0.000* 
 
SvMCI>control 
SvaD>control 
Daytime DBP  88.07±7.95 84.38±7.79 82.21±4.40 0.109     
Nighttime DBP  84.04±9.81 82.95±9.30 78.15±7.83 0.031*  SvMCI>control   
PP  053.54±10.55  056.96±10.30 46.34±5.14 0.000*  SVaD>control 
SBP variability  13.60±4.80 15.71±3.40 12.37±3.80 0.047*  SVaD>control 
Diurnal BP pattern           
Dipper 
 
12 (33%)  
 
7 (15%)  
 
20 (65%) 
 
0.000* 
 
SVaD>SvMCI 
SvMCI>control 
Nondipper 17  (45%) 27  (65%)  08 (30%)       
Reversed dipper  08 (22%)  08 (20%)  02 (5%)       
*p<0.05. SBP: systolic blood pressure, DBP: diastolic blood pressure, PP: pulse pressure. 
 
Table 3. Odds ratios (ORs) and 95% confidence intervals (CIs) for
the SvMCI/SVaD group for conventional risk factors and 24-hour 
values 
Variable  OR  95% CI  p 
Age (years)      
 <70  1.0     
 >70  1.833  0.907-3.704  0.091 
Sex (M/F, reference: F) 1.274  0.6783-2.047  0.572 
HTN 1.037  0.611-1.759  0.893 
DM 1.067    0.527-2.157  0.857 
LDL 1.20  0.518-2.777  0.670 
SM 1.00  0.375-2.664  1.000 
LVH 1.40  0.622-3.152  0.416 
24-hour BP values       
 Daytime  SBP       
 LG  1.00     
   HG  0.833  0.490-1.417  0.501 
   Nighttime SBP       
   LG  1.00     
   HG  0.967  0.580-1.610  0.896 
   Nighttime DBP       
   LG  1.00     
   HG  1.097  0.674-1.784  0.782 
BP dipping status       
 Dipper  1.00     
 Nondipper  4.827  1.07-12.05  0.039* 
   Reverse dipper  1.40  0.622-3.152  0.416 
SBP variability       
 LG  1.00     
 HG  1.117  0.451-2.765  0.811 
PP      
 LG  1.00     
   HG  1.254  0.579-4.210 0.710 
*p<0.05. SvMCI: subcortical vascular mild cognitive impairment, 
SVaD: subcortical vascular dementia, HTN: hypertension, HG: 
high group, LG:  low group, DM:  diabetes mellitus, LDL:  low-
density lipoprotein cholesterol, BP: blood pressure, SBP: systolic 
blood pressure, DBP: diastolic blood pressure. 
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have been predictive of the cerebral-lesion type. Very few 
studies have investigated the relationship between the dy-
namic changes in BP and subcortical ischemic VCI, includ-
ing SvMCI and SVaD, in the same cohort of subjects.
25 
Previous studies employing ABP monitoring found that 
the mean SBP was higher in patients with SVaD than in con-
trols, a finding that differs somewhat from those of the pre-
sent study showing that the SBP was higher in the patients 
with SvMCI than in the control and SVaD groups.
26,27 How-
ever, the reason for these differences is unclear since the BP 
levels of the subjects in the present study were contaminat-
ed by antihypertensive medication. SBP variability and PP 
were significantly higher in the SVaD patients, indicating a 
possible association with the loss of vasomotor reactivity 
in advanced small-vessel lesions. 
Many studies have found a close relationship between SBP 
variability and Binswanger’s disease.
28,29 A high PP reflects 
increased arterial stiffness, and the penetrating cerebral ar-
teries of hypertensive patients with high PP show lower re-
sponses to hypotension, increasing the risk of developing W-
MLs.
29 There is increasing evidence that elevated arterial stiff-
ness increases the risk of cardiovascular complications.
30,31 
A recent notable finding related to 24-hour BP is the pro-
minent loss of diurnal BP rhythm in Binswanger’s disease.
26 
The same researchers also found that nondippers were more 
prevalent in the SvMCI and SVaD groups than in the control 
group. The precise relationship between subcortical small-
vessel lesions and loss of dipping is controversial, with some 
researchers (e.g., van Boxtel et al.)14 suggesting that dip-
ping status is unrelated to cerebral pathology. However, many 
other studies (including our own) have found that nondipping 
is closely related to possible hypertensive target-organ dam-
age, and that nondipping and reverse-dipping statuses are 
more common in patients with subcortical small-vessel is-
chemia.
9,13,24,27 It was also found that reduced attention, visu-
ospatial dysfunction, and frontal executive dysfunctions are 
related to loss of dipping. 
The clinical manifestations of SVaD result from disruption 
to the subcortical-frontal systems, particularly the dorsolateral 
prefrontal-subcortical circuits.
33 The characteristic neuropsy-
chological profile of cerebral small-vessel disease includes 
early attention and executive function impairment, with slow-
ing of motor performance and information processing.
1 This 
has been confirmed in studies showing that subcortical gray-
and white-matter hyperintensity volumes and scores on white-
matter rating scales on MRI scans are significantly correlat-
ed with the degree of neuropsychological dysfunction in dif-
ferent patient populations.
 In addition, we showed that these 
cognitive dysfunctions in patients with SVaD were corre-
lated with the changes in their diurnal BP rhythm. 
The limitations of this study are 1) its relatively small sam-
ple, 2) the absence of a prospective follow-up investigation, 
and 3) the absence of established SvMCI criteria; it is pos-
sible that some of the patients in our cognitively impaired 
groups were suffering from amnestic MCI. However, we did 
attempt to exclude those patients with pure amnestic MCI 
by applying detailed neuropsychological testing, brain im-
aging, and history-taking. 
To the best of our knowledge, the present study is the first 
to compare SvMCI and SVaD through ABP monitoring, and 
to analyze the relationships between 24-hour BP data, sub-
cortical-ischemic-lesion types, and cognitive performance. 
Based on the results of this study, it is suggested that the 
ABP profile is related to the progression characteristics of 
subcortical small-vessel disease. The ABP profile might be 
predictive of the progression of subcortical WML in patients 
with subcortical VCI, which suggests that BP control should 
be considered as a wide-ranging target for the prevention 
of SVaD. Modulating the loss of dipping and the increase in 
SBP variability and PP in SvMCI patients could help prevent 
advanced subcortical small-vessel disease, while simultane-
ously lowering the BP. 
Table 4. Age- and education-adjusted correlation between 24-hour BP values and scores in each cognitive domain of Neuropsychological 
Screening Battery (SNSB) tests in SvMCI/SVaD patients 
SNSB test  Attention  Language function  Visuospatial function  Memory  Frontal executive function 
Levels of 24-hour BP values                
Daytime SBP  -0.031  -0.074  -0.051  -0.055  -0.129 
Nighttime SBP  -0.222  -0.063  -0.052  -0.148  -0.114 
Daytime DBP  -0.017  -0.089  -0.038  -0.045  -0.130 
Nighttime DBP  -0.205  -0.043  -0.102  -0.188  -0.045 
BP dip  -0.267*  -0.030  -0.151  -0.146  -0.348** 
PP -0.258*  -0.171  -0.046  -0.076 -0.052 
AASI -0.043  -0.030  -0.053  -0.093 -0.018 
SBP variability  -0.355**  -0.055 -0.305**  -0.111  -0.243* 
*p<0.05, **p<0.01.  
AASI: Ambulatory Arterial Stiffness index, SBP: systolic BP, DBP: diastolic BP, BP: blood pressure, PP: pulse pressure. 
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